Publication
Euphorbia denticulata Lam.: a promising source of phyto-pharmaceuticals for the development of novel functional formulations
dc.contributor.author | Zengin, Gokhan | |
dc.contributor.author | Uysal, Ahmet | |
dc.contributor.author | Aktumsek, Abdurrahman | |
dc.contributor.author | Mocan, Andrei | |
dc.contributor.author | Mollica, Adriano | |
dc.contributor.author | Locatelli, Marcello | |
dc.contributor.author | Custódio, Luísa | |
dc.contributor.author | Neng, Nuno R. | |
dc.contributor.author | Nogueira, Jose M. F. | |
dc.contributor.author | Aumeeruddy-Elalfi, Zaahira | |
dc.contributor.author | Mahomoodally, M. Fawzi | |
dc.date.accessioned | 2019-11-20T15:07:47Z | |
dc.date.available | 2019-11-20T15:07:47Z | |
dc.date.issued | 2017-03 | |
dc.description.abstract | In this study, Methanolic extracts of Euphorbia denticulata parts (flowers, leaf, stem, and mix of aerial parts) were assessed for a panoply of bioactivities. Inhibitory potential against key enzymes involved in diabetes (alpha-glucosidase and alpha-amylase), obesity (pancreatic lipase), neurodegenerative diseases (cholinesterases), and hyperpigmentation (tyrosinase) was evaluated. The antioxidant and antibacterial properties were also assessed. The total phenolic, flavonoid, and phytochemical profile were established using HPLC/DAD and molecular modelling studies on specific target compounds were performed in silico. The flower extract was found to be rich in phenolics and flavonoids, (60.11 +/- 1.40 mgGAE/g and 42.04 +/- 0.16 mgRE/g respectively), which tend to correlate with the high radical scavenging activity of this extract (120.34 +/- 3.33 mgTE/g and 165.42 +/- 2.16 mgTE/g for DPPH and ABTS respectively). Catechin, epicatechin, gallic acid, p-OH-Benzoic acid, rosmarinic acid, and epigallocatechin gallate, found in significant abundance in the extracts were assessed using molecular modelling with the aim to study their docking properties on a set of six enzymes used in this study. The extracts were moderately effective with MIC values ranging between 1.56 to 6.25 mg/ml, but potent growth inhibitors of MRSA strains. Results amassed herein can be used as a stimulus for further studies geared towards the development of novel phyto-pharmaceuticals. (C) 2016 Elsevier Masson SAS. All rights reserved. | |
dc.identifier.doi | 10.1016/j.biopha.2016.12.063 | |
dc.identifier.issn | 0753-3322 | |
dc.identifier.issn | 1950-6007 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/13212 | |
dc.language.iso | eng | |
dc.peerreviewed | yes | |
dc.publisher | Elsevier France | |
dc.subject | Alpha-glucosidase | |
dc.subject | Pancreatic lipase | |
dc.subject | Rosmarinic acid | |
dc.subject | In-vitro | |
dc.subject | Antioxidant activities | |
dc.subject | Crystal-structure | |
dc.subject | Medicinal-plants | |
dc.subject | Rat-brain | |
dc.subject | Polyphenols | |
dc.subject | Inhibition | |
dc.title | Euphorbia denticulata Lam.: a promising source of phyto-pharmaceuticals for the development of novel functional formulations | |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 36 | |
oaire.citation.startPage | 27 | |
oaire.citation.title | Biomedicine & Pharmacotherapy | |
oaire.citation.volume | 87 | |
person.familyName | Custódio | |
person.givenName | Luísa | |
person.identifier.ciencia-id | 791B-C560-AEA2 | |
person.identifier.orcid | 0000-0003-4338-7703 | |
person.identifier.rid | M-6101-2013 | |
person.identifier.scopus-author-id | 15831018900 | |
rcaap.rights | restrictedAccess | |
rcaap.type | article | |
relation.isAuthorOfPublication | f9cfed0f-6b67-413e-988c-ac7397183471 | |
relation.isAuthorOfPublication.latestForDiscovery | f9cfed0f-6b67-413e-988c-ac7397183471 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 13212 linha 53 Zengin-2017-Euphorbia-denticulata-lam-a-promisi.pdf
- Size:
- 2.16 MB
- Format:
- Adobe Portable Document Format